Genetic modification of xenografts

Current Topics in Microbiology and Immunology

Volumn 278, Issue , 2003, Pages 1-21

  Platt, J L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA MODIFICATION; GENE EXPRESSION; GENETIC ENGINEERING; HUMAN; HYPERACUTE GRAFT REJECTION; INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALIA;

EID: 0042164585     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-55541-1_1     Document Type: Review

References (92)

1. Artrip JH, Kwiatkowski P, Michler RE, et al. 1999 Target cell susceptibility to lysis by human natural killer cells is augmented by alpha(1,3)-galactosyltransferase and reduced by alpha(1,2)-fucosyltransferase. J Biol Chem 274:10717-10722
2. Auchincloss H, Jr. 1988 Xenogeneic transplantation. Transplantation 46:1-20
3. Auchincloss Jr. H, and Sachs DH 1998 Xenogeneic transplantation. Annu Rev Immunol 16:433-470
4. Bach FH, Ferran C, Hechenleitner P, et al. 1997 Accommodation of vascularized xenografts: expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3:196-204
5. Bach FH, Winkler H, Ferran C, et al. 1996 Delayed xenograft rejection. Immunol Today 17:379-384
6. Bannett AD, McAlack RF, Morris M, et al. 1989 ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplant. Transplant Proc 21:783-785
7. Betthauser J, Forsberg E, Augenstein M, et al. 2000 Production of cloned pigs from in vitro systems. Nat Biotechnol 18:1055-1059
8. Bhatti FNK, Schmoeckel M, Zaidi A, et al. 1999 Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant Proc 31:958
9. Blakely ML, Van Der Werf WJ, Berndt MC, et al. 1994 Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 58:1059-1066
10. Brauer RB, Baldwin III WM, Daha MR, et al. 1993 Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 151:7240-7248
11. Bustos M, Saadi S, and Platt JL (2001) Platelet-mediated activation of endothelial cells: implications for the pathogenesis of transplant rejection. Transplantation 72:509-515
12. Byrne GW, McCurry KR, Martin MJ, et al. 1997 Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63:149-155
13. Calne RY, Davis DR, Pena JR, et al. 1970 Hepatic allografts and xenografts in primates. Lancet 1:103-106
14. Calne RY, White HJO, Herbertson BM, et al. 1968 Pig-to-baboon liver xenografts. Lancet 1:1176-1178
15. Cascalho M, and Platt JL 2001 The immunological barrier to xenotransplantation. Immunity 14:437-446
16. Chapman LE, Folks TM, Salomon DR, et al. 1995 Xenotransplantation and xenogeneic infections. New Eng J Med 333:1498-1501
17. Chen CG, Salvaris EJ, Romanella M, et al. 1998 Transgenic expression of human alpha1,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection. Transplantation 65:832-837
18. Chopek MW, Simmons RL, and Platt JL 1987 ABO-incompatible renal transplantation: initial immunopathologic evaluation. Transplant Proc 19:4553-4557
19. Cooper DKC, Human PA, Lexer G, et al. 1988 Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transpl 7:238-246
20. Cozzi E, Yannoutsos N, Langford GA, et al. 1997 Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs. 2nd ed. In Xenotransplantation: the transplantation of organs and tissues between species. Cooper DKC, Kemp E, Platt JL, et al., editors. Springer, Berlin. 665-682
21. Daggett CW, Yeatman M, Lodge AJ, et al. 1998 Total respiratory support from swine lungs in primate recipients. J Thorac Cardiovasc Surg 115:19-27
22. Dai Y, Vaught TD, Boone J, Chen S, Phelps CJ, Ball S, Monahan JA, Jobst PM, McCreath KJ, Lamborn AE, Cowell JL, Wells KD, Colman A, Polejaeva IA, Ayares DL 2002 Nature Biotechnology 20:251-255
23. Dalmasso AP, Benson BA, Johnson JS, et al. 2000 Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal al pha(1-3)Gal binding lectin: up-regulation of CD59 expression. J Immunol 164:3764-3773
24. Dalmasso AP, Vercellotti GM, Fischel RJ, et al. 1992 Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 140:1157-1166
25. Dalmasso AP, Vercellotti GM, Platt JL, et al. 1991 Inhibition of complement-mediated endothelial cell cytotoxicity by decay accelerating factor: potential for prevention of xenograft hyperacute rejection. Transplantation 52:530-533
26. Deacon T, Schumacher J, Dinsmore J, et al. 1997 Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 3:350-353
27. Dean PG, Kim DY, Ninova, et al. 2001 Induction of Heme oxygenase-1 with cobalt protoporphyrin fails to prolong hamster-to-rat kidney xenograft survival. (Abstract 1266). Am J Transplant 1[Suppl 1]:456
28. Delikouras A, Hayes M, Malde P, et al. (2001) Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from TNFα-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation
29. Diamond LE, McCurry KR, Oldham ER, et al. 1996 Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 61:1241-1249
30. Diamond LE, Quinn CM, Martin MJ, et al. 2001 A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 71:132-142
31. Evans RW 2001 Coming to terms with reality: why xenotransplantation is a necessity. In Xenotransplantation. Platt JL, editor. ASM Press, Washington, D. C. 29-51
32. Evans RW, Orians CE, and Ascher NL 1992 The potential supply of organ donors: an assessment of the efficiency of organ procurement efforts in the United States. JAMA 267:239-246
33. Galili U, Clark MR, Shohet SB, et al. 1987 Evolutionary relationship between the natural anti-Gal antibody and the Gal α1-3Gal epitope in primates. Proc Natl Acad Sci USA 84:1369-1373
34. Gritsch HA, Glaser RM, Emery DW, et al. 1994 The importance of nonimmune factors in reconstitution by discordant xenogeneic hematopoietic cells. Transplantation 57:906-917
35. Gunsalus JR, Brady DA, Coulter SM, et al. 1997 Reduction of serum cholesterol in watanabe rabbits by xenogeneic hepatocellular transplantation. Nat Med 3:48-53
36. Halloran PF, Melk A, and Barth C 1999 Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 10:167-181
37. Hammer C 1998 Physiological obstacles after xenotransplantation. Ann N Y Acad Sci 862:19-27
38. Hancock WW, Buelow R, Sayegh MH, et al. 1998 Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 4:1392-1396
39. Holzknecht ZE, Coombes S, Blocher BA, et al. 2001 Immune complex formation after xenotransplantation: evidence of type III as well as type II immune reactions provide clues to pathophysiology. Am J Pathol 158:627-637
40. Inverardi L, Samaja M, Motterlini R, et al. 1992 Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 149:1416-1423
41. Itescu S, Artrip JH, Kwiatkowski PA, et al. 1997 Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products. Ann Transplant 2:14-20
42. Jurd KM, Gibbs RV, and Hunt BJ 1996 Activation of human prothrombin by porcine aortic endothelial cells-a potential barrier to pig to human xenotransplantation. Blood Coagul Fibrinolysis 7:336-343
43. Kanai N, and Platt JL 2000 Xenotransplantation of the liver. Clinics in Liver Disease 4:731-746
44. Kaufman DB, Platt JL, Rabe F, et al. 1990 Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med 172:291-302
45. Kobayashi T, Taniguchi S, Ye Y, et al. 1996 Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor. Transplant Proc 28:560
46. Lai L, Prather RS 2002 Progress in producing knockout models for xenotransplantation by nuclean transfer. Annals of Medicine 34:501-506
47. Lawson JH, and Platt JL 1996 Molecular barriers to xenotransplantation. Transplantation 62:303-310
48. Leventhal JR, Dalmasso AP, Cromwell JW, et al. 1993a Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 55:857-866
49. Leventhal JR, Matas AJ, Sun LH, et al. 1993b The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 56:1-8
50. Lin SS, Hanaway MJ, Gonzalez-Stawinski GV, et al. 2000 The role of anti-Galα1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation (Rapid Communication) 70:1667-1674
51. Lin SS, Kooyman DL, Daniels LJ, et al. 1997 The role of natural anti-Galα1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transpl Immunol 5:212-218
52. Lin SS, Weidner BC, Byrne GW, et al. 1998 The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 101:1745-1756
53. Logan JS, and Martin MJ 1994 Transgenic swine as a recombinant production system for human hemoglobin. Methods Enzymol 231:435-445
54. Magee JC, Collins BH, Harland RC, et al. 1995 Immunoglobulin prevents complement mediated hyperacute rejection in swine-to-primate xenotransplantation. J Clin Invest 96:2404-2412
55. Malyguine AM, Saadi S, Holzknecht RA, et al. 1997 Induction of procoagulant function in porcine endothelial cells by human NK cells. J Immunol 159:4659-4664
56. Mazzucato M, De Marco L, Pradella P, et al. 1996 Porcine von Willebrand factor binding to human platelet GPIb induces transmembrane calcium influx. Thromb Haemost 75:655-660
57. McCreath KJ, Howcroft J, Campbell KHS, et al. 2000 Production of gene-targeted sheep by nuclear transfer from cultured somatic cells. Nature 405:1066-1069
58. McCurry KR, Kooyman DL, Alvarado CG, et al. 1995 Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1:423-427
59. Mueller YM, Davenport C, and Ildstad ST 1999 Xenotransplantation: application of disease resistance. Clin Exp Pharmacol Physiol 26:1009-1012
60. Nagano H, Mitchell RN, Taylor MK, et al. 1997 Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 100:550-557
61. Nagata H, Ito M, Cai J, Edge AS, Platt JL, Fox IJ 2003 Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology 124:422-431
62. Nagayasu T, and Platt JL 1998 Progress in xenotransplantation. Graft 1:19-24
63. Nagayasu T, Saadi S, Holzknecht RA, et al. 2000 Expression of tissue factor mRNA in cardiac xenografts: clues to the pathogenesis of acute vascular rejection. Transplantation 69:475-482
64. Onishi A, Iwamoto M, Akita T, et al. 2000 Pig cloning by microinjection of fetal fibroblast nuclei. Science 289:1188-1190
65. Osman N, McKenzie IF, Ostenried K, et al. 1997 Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3) Gal. Proc Natl Acad Sci 94:14677-14682
66. Parker W, Lin SS, and Platt JL 2001 Antigen expression in xenotransplantation: how low must it go? Transplantation 71:313-319
67. Patience C, Takeuchi Y, and Weiss RA 1997 Infection of human cells by an endogenous retrovirus of pigs. Nat Med 3:282-286
68. Perper RJ, and Najarian JS 1966 Experimental renal heterotransplantation. I. In widely divergent species. Transplantation 4:377-388
69. Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, Ball S, Specht SM, Polejaeva IA, Monahan JA, Jobst PM, Sharma SB, Lamborn AE, Varst AS, Moore M, Demetris AJ, Rudert WA, Bottino R, Bertera S, Trucco M, Starzl TE, Dai Y, Hyares DL 2003 Production of α1,3-galactosyltransferase-deficient pigs. Science 299:411-414
70. Platt JL 1998 New directions for organ transplantation. Nature 392 (Suppl): 11-17
71. Platt JL 2001 Xenotransplantation of the liver: is more complement control needed? Liver Transpl 7(10):933-934
72. Platt JL, Fischel RJ, Matas AJ, et al. 1991 Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 52:214-220
73. Platt JL, and Nath KA 1998 Heme oxygenase: protective gene or Trojan horse. Nat Med 4:1364-1365
74. Platt JL, Vercellotti GM, Dalmasso AP, et al. 1990a Transplantation of discordant xenografts: a review of progress. Immunol Today 11:450-456
75. Platt JL, Vercellotti GM, Lindman BJ, et al. 1990b Release of heparan sulfate from endothelial cells: implications for the pathogenesis of hyperacute rejection. J Exp Med 171:1363-1368
76. Polejaeva IA, Chen S, Vaught TD, et al. 2000 Cloned piglets produced by nuclear transfer from adult somatic cells. Nature 407:86-90
77. Pruitt SK, Kirk AD, Bollinger RR, et al. 1994 The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57:363-370
78. Ramirez P, Chavez R, Majado M, et al. 2000 Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the met abolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation 70:989-998
79. Sachs DH, and Sablinski T 1995 Tolerance across discordant xenogeneic barriers. Xenotransplantation 2:234-239
80. Sandrin MS, Fodor WL, Mouhtouris E, et al. 1995 Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1:1261-1267
81. Sandrin MS, and McKenzie IF 1999 Recent advances in xenotransplantation. Curr Opin Immunol 11:527-531
82. Sandrin MS, Vaughan HA, Dabkowski PL, et al. 1993 Anti-pig IgM antibodies in human serum react predominantly with Galα(1,3)Gal epitopes. Proc Natl Acad Sci 90:11391-11395
83. Schmoeckel M, Bhatti FNK, Zaidi A, et al. 1997 Xenotransplantation of pig organs transgenic for human DAF: an update. Transplant Proc 29:3157-3158
84. Sharma A, Okabe JF, Birch P, et al. 1996 Reduction in the level of Gal (α1,3) Gal in transgenic mice and pigs by the expression of an α(1,2) fucosyltransferase. Proc Natl Acad Sci 93:7190-7195
85. Soares MP, Lin Y, Anrather J, et al. 1998 Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4:1073-1077
86. Starzl TE, Fung J, Tzakis A, et al. 1993 Baboon-to-human liver transplantation. Lancet 341:65-71
87. Valdivia LA, Fung JJ, Demetris AJ, et al. 1994 Donor species complement after liver xenotransplantation. Transplantation 57:918-922
88. Waaga AM, Gasser M, Laskowski I, et al. 2000 Mechanisms of chronic rejection. Curr Opin Immunol 12:517-521
89. Waterworth PD, Dunning J, Tolan M, et al. 1998 Life-supporting pig-to-baboon heart xenotransplantation. J Heart Lung Transplant 17:1201-1207
90. Yu PB, Holzknecht ZE, Bruno D, et al. 1996 Modulation of natural IgM binding and complement activation by natural IgG antibodies. J Immunol 157:5163-5168
91. Yuzawa Y, Brett J, Fukatsu A, et al. 1995 Interaction of antibody with forssman antigen in guinea pigs. Am J Pathol 146:1260-1272
92. Zaidi A, Schmoeckel M, Bhatti F, et al. 1998 Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 65:1584-1590